State Street Corp. Updates Passive Stake in uniQure N.V.
Ticker: QURE · Form: SC 13G/A · Filed: Jan 25, 2024 · CIK: 1590560
| Field | Detail |
|---|---|
| Company | Uniqure N.V. (QURE) |
| Form Type | SC 13G/A |
| Filed Date | Jan 25, 2024 |
| Risk Level | low |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, passive-investment
TL;DR
**State Street still holds uniQure stock, signaling continued institutional confidence.**
AI Summary
State Street Corporation, a major financial institution, filed an amended SC 13G/A on January 25, 2024, indicating its ownership of uniQure N.V. common stock as of December 31, 2023. This filing, under Rule 13d-1(b), updates their previous disclosure regarding their passive investment in the pharmaceutical company. For investors, this means a significant institutional holder continues to maintain a position in uniQure, potentially signaling ongoing confidence in the company's long-term prospects.
Why It Matters
This filing confirms State Street Corporation's continued passive investment in uniQure N.V., which can be a positive signal for current and prospective shareholders, indicating institutional interest and stability.
Risk Assessment
Risk Level: low — This filing is an update from a passive institutional investor and does not indicate any immediate change in company operations or significant new risks.
Analyst Insight
Investors should note State Street's continued passive holding as a sign of institutional presence, but this filing alone doesn't suggest a change in uniQure's fundamentals or warrant immediate action. It's a routine update from a large asset manager.
Key Players & Entities
- State Street Corporation (company) — the reporting person and institutional investor
- uniQure N.V. (company) — the subject company whose common stock is being reported
- 0000093751-24-000212 (dollar_amount) — accession number for the filing
- December 31, 2023 (date) — the date of the event requiring the filing
- N90064101 (dollar_amount) — CUSIP number for uniQure N.V. common stock
FAQ
What type of filing is this document and what does it signify?
This document is an SC 13G/A, which is an amendment to a Schedule 13G. It signifies that State Street Corporation is updating its previous disclosure regarding its beneficial ownership of uniQure N.V. common stock, specifically under Rule 13d-1(b).
Who is the reporting person in this filing?
The reporting person in this filing is State Street Corporation, identified by IRS Identification No. 04-2456637 and located at 1 Congress Street, Boston, MA.
What is the subject company whose securities are being reported?
The subject company is uniQure N.V., a pharmaceutical preparations company with CIK 0001590560, whose common stock is the title of the class of securities being reported.
What was the date of the event that required this filing?
The date of the event which required the filing of this statement was December 31, 2023, as stated on the cover page of the filing.
Under which specific rule was this Schedule 13G filed?
This Schedule 13G was filed under Rule 13d-1(b), as indicated by the 'X' next to 'RULE 13D-1 (B)' on the cover page.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on January 25, 2024 regarding uniQure N.V. (QURE).